• mail us help@24marketresearch.com
  • Int'l 1(332) 2424 294 (Int'l)

purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Non-Invasive Drug Delivery
1.2 Key Market Segments
1.2.1 Non-Invasive Drug Delivery Segment by Type
1.2.2 Non-Invasive Drug Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Non-Invasive Drug Delivery Market Overview
2.1 Global Market Overview
2.1.1 Global Non-Invasive Drug Delivery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Non-Invasive Drug Delivery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Non-Invasive Drug Delivery Market Competitive Landscape
3.1 Global Non-Invasive Drug Delivery Sales by Manufacturers (2019-2024)
3.2 Global Non-Invasive Drug Delivery Revenue Market Share by Manufacturers (2019-2024)
3.3 Non-Invasive Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Non-Invasive Drug Delivery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Non-Invasive Drug Delivery Sales Sites, Area Served, Product Type
3.6 Non-Invasive Drug Delivery Market Competitive Situation and Trends
3.6.1 Non-Invasive Drug Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Non-Invasive Drug Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Non-Invasive Drug Delivery Industry Chain Analysis
4.1 Non-Invasive Drug Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Non-Invasive Drug Delivery Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Non-Invasive Drug Delivery Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Non-Invasive Drug Delivery Sales Market Share by Type (2019-2024)
6.3 Global Non-Invasive Drug Delivery Market Size Market Share by Type (2019-2024)
6.4 Global Non-Invasive Drug Delivery Price by Type (2019-2024)
7 Non-Invasive Drug Delivery Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Non-Invasive Drug Delivery Market Sales by Application (2019-2024)
7.3 Global Non-Invasive Drug Delivery Market Size (M USD) by Application (2019-2024)
7.4 Global Non-Invasive Drug Delivery Sales Growth Rate by Application (2019-2024)
8 Non-Invasive Drug Delivery Market Segmentation by Region
8.1 Global Non-Invasive Drug Delivery Sales by Region
8.1.1 Global Non-Invasive Drug Delivery Sales by Region
8.1.2 Global Non-Invasive Drug Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Non-Invasive Drug Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Non-Invasive Drug Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Non-Invasive Drug Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Non-Invasive Drug Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Non-Invasive Drug Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Adherium Limited
9.1.1 Adherium Limited Non-Invasive Drug Delivery Basic Information
9.1.2 Adherium Limited Non-Invasive Drug Delivery Product Overview
9.1.3 Adherium Limited Non-Invasive Drug Delivery Product Market Performance
9.1.4 Adherium Limited Business Overview
9.1.5 Adherium Limited Non-Invasive Drug Delivery SWOT Analysis
9.1.6 Adherium Limited Recent Developments
9.2 Capsule Technologies, Inc.
9.2.1 Capsule Technologies, Inc. Non-Invasive Drug Delivery Basic Information
9.2.2 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Overview
9.2.3 Capsule Technologies, Inc. Non-Invasive Drug Delivery Product Market Performance
9.2.4 Capsule Technologies, Inc. Business Overview
9.2.5 Capsule Technologies, Inc. Non-Invasive Drug Delivery SWOT Analysis
9.2.6 Capsule Technologies, Inc. Recent Developments
9.3 Crossject S.A.
9.3.1 Crossject S.A. Non-Invasive Drug Delivery Basic Information
9.3.2 Crossject S.A. Non-Invasive Drug Delivery Product Overview
9.3.3 Crossject S.A. Non-Invasive Drug Delivery Product Market Performance
9.3.4 Crossject S.A. Non-Invasive Drug Delivery SWOT Analysis
9.3.5 Crossject S.A. Business Overview
9.3.6 Crossject S.A. Recent Developments
9.4 Diabeloop SA
9.4.1 Diabeloop SA Non-Invasive Drug Delivery Basic Information
9.4.2 Diabeloop SA Non-Invasive Drug Delivery Product Overview
9.4.3 Diabeloop SA Non-Invasive Drug Delivery Product Market Performance
9.4.4 Diabeloop SA Business Overview
9.4.5 Diabeloop SA Recent Developments
9.5 HNS International, Inc.
9.5.1 HNS International, Inc. Non-Invasive Drug Delivery Basic Information
9.5.2 HNS International, Inc. Non-Invasive Drug Delivery Product Overview
9.5.3 HNS International, Inc. Non-Invasive Drug Delivery Product Market Performance
9.5.4 HNS International, Inc. Business Overview
9.5.5 HNS International, Inc. Recent Developments
9.6 Inovio Pharmaceuticals, Inc.
9.6.1 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Basic Information
9.6.2 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Overview
9.6.3 Inovio Pharmaceuticals, Inc. Non-Invasive Drug Delivery Product Market Performance
9.6.4 Inovio Pharmaceuticals, Inc. Business Overview
9.6.5 Inovio Pharmaceuticals, Inc. Recent Developments
9.7 Medtronic Plc.
9.7.1 Medtronic Plc. Non-Invasive Drug Delivery Basic Information
9.7.2 Medtronic Plc. Non-Invasive Drug Delivery Product Overview
9.7.3 Medtronic Plc. Non-Invasive Drug Delivery Product Market Performance
9.7.4 Medtronic Plc. Business Overview
9.7.5 Medtronic Plc. Recent Developments
9.8 Novartis AG
9.8.1 Novartis AG Non-Invasive Drug Delivery Basic Information
9.8.2 Novartis AG Non-Invasive Drug Delivery Product Overview
9.8.3 Novartis AG Non-Invasive Drug Delivery Product Market Performance
9.8.4 Novartis AG Business Overview
9.8.5 Novartis AG Recent Developments
9.9 PenJet Corporation
9.9.1 PenJet Corporation Non-Invasive Drug Delivery Basic Information
9.9.2 PenJet Corporation Non-Invasive Drug Delivery Product Overview
9.9.3 PenJet Corporation Non-Invasive Drug Delivery Product Market Performance
9.9.4 PenJet Corporation Business Overview
9.9.5 PenJet Corporation Recent Developments
9.10 PharmaJet
9.10.1 PharmaJet Non-Invasive Drug Delivery Basic Information
9.10.2 PharmaJet Non-Invasive Drug Delivery Product Overview
9.10.3 PharmaJet Non-Invasive Drug Delivery Product Market Performance
9.10.4 PharmaJet Business Overview
9.10.5 PharmaJet Recent Developments
9.11 Portal Instruments
9.11.1 Portal Instruments Non-Invasive Drug Delivery Basic Information
9.11.2 Portal Instruments Non-Invasive Drug Delivery Product Overview
9.11.3 Portal Instruments Non-Invasive Drug Delivery Product Market Performance
9.11.4 Portal Instruments Business Overview
9.11.5 Portal Instruments Recent Developments
9.12 ResMed
9.12.1 ResMed Non-Invasive Drug Delivery Basic Information
9.12.2 ResMed Non-Invasive Drug Delivery Product Overview
9.12.3 ResMed Non-Invasive Drug Delivery Product Market Performance
9.12.4 ResMed Business Overview
9.12.5 ResMed Recent Developments
9.13 Sensiron AG
9.13.1 Sensiron AG Non-Invasive Drug Delivery Basic Information
9.13.2 Sensiron AG Non-Invasive Drug Delivery Product Overview
9.13.3 Sensiron AG Non-Invasive Drug Delivery Product Market Performance
9.13.4 Sensiron AG Business Overview
9.13.5 Sensiron AG Recent Developments
9.14 Tandem Diabetes Care, Inc.
9.14.1 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Basic Information
9.14.2 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Overview
9.14.3 Tandem Diabetes Care, Inc. Non-Invasive Drug Delivery Product Market Performance
9.14.4 Tandem Diabetes Care, Inc. Business Overview
9.14.5 Tandem Diabetes Care, Inc. Recent Developments
9.15 Teva Pharmaceuticals Industries Ltd.
9.15.1 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Basic Information
9.15.2 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Overview
9.15.3 Teva Pharmaceuticals Industries Ltd. Non-Invasive Drug Delivery Product Market Performance
9.15.4 Teva Pharmaceuticals Industries Ltd. Business Overview
9.15.5 Teva Pharmaceuticals Industries Ltd. Recent Developments
10 Non-Invasive Drug Delivery Market Forecast by Region
10.1 Global Non-Invasive Drug Delivery Market Size Forecast
10.2 Global Non-Invasive Drug Delivery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Non-Invasive Drug Delivery Market Size Forecast by Country
10.2.3 Asia Pacific Non-Invasive Drug Delivery Market Size Forecast by Region
10.2.4 South America Non-Invasive Drug Delivery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Non-Invasive Drug Delivery by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Non-Invasive Drug Delivery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Non-Invasive Drug Delivery by Type (2025-2030)
11.1.2 Global Non-Invasive Drug Delivery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Non-Invasive Drug Delivery by Type (2025-2030)
11.2 Global Non-Invasive Drug Delivery Market Forecast by Application (2025-2030)
11.2.1 Global Non-Invasive Drug Delivery Sales (K Units) Forecast by Application
11.2.2 Global Non-Invasive Drug Delivery Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings